ロード中...
Frequent ESR1 and CDK Pathway Copy Number Alterations in Metastatic Breast Cancer
DNA sequencing has identified a limited number of driver mutations in metastatic breast cancer beyond single base-pair mutations in the estrogen receptor (ESR1). However, our previous studies and others have observed that structural variants, such as ESR1 fusions, may also play a role. Therefore, we...
保存先:
| 出版年: | Mol Cancer Res |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6359977/ https://ncbi.nlm.nih.gov/pubmed/30355675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-18-0946 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|